Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Moderna Inc
Recent news which mentions Moderna Inc
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Stocks making the biggest moves midday: Pfizer, Lucid, WSFS Financial and more
June 26, 2023
Tags
Business
Market Insider
Pfizer Inc
From
CNBC.com News
Stocks making the biggest premarket moves: Tesla, Moderna, Alphabet, PacWest and more
June 26, 2023
Tags
Stock markets
stocks
Business
From
CNBC.com News
Moderna files for FDA approval of updated Covid vaccine for fall
June 22, 2023
Tags
Health & Science
Science
Pfizer Inc
From
CNBC.com News
Pfizer, Moderna and Novavax gear up for fall Covid vaccine rollout with an important head start
June 20, 2023
Tags
Health care industry
Novavax Inc
Immunizations
From
CNBC.com News
FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall
June 16, 2023
Tags
Business
US: News
Health & Science
From
CNBC.com News
FDA advisors raise doubts about seasonal updates to Covid vaccines as with flu shots
June 16, 2023
Tags
Companies
Biotechnology
Coronavirus
From
CNBC.com News
FDA advisors recommend that new Covid vaccines target an omicron XBB variant this fall
June 15, 2023
Tags
Immunizations
Moderna Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Covid vaccine maker Novavax sees a pathway to survival – but it won’t be easy
June 14, 2023
Tags
Coronavirus
Vaccinations
Biotechnology
From
CNBC.com News
Updated Covid vaccines need to target XBB omicron variants this fall, FDA staff says
June 12, 2023
Tags
Business News
Novavax Inc
Health care industry
From
CNBC.com News
Moderna cancer vaccine used with Merck Keytruda reduces risk of deadly skin cancer spreading
June 05, 2023
Tags
Business
US: News
Health & Science
From
CNBC.com News
As the market starts to cool down, Cramer says don't be afraid to stay bullish
June 03, 2023
Tags
Investing
Mad Money
Merck & Co Inc
From
CNBC.com News
Cramer says the money's in tech this year, tread carefully when it comes to any other sector
May 30, 2023
Tags
Investment Strategy
stocks
Leidos Holdings Inc
From
CNBC.com News
Stocks making the biggest moves midday: Abercrombie & Fitch, Palo Alto Networks, Moderna and more
May 24, 2023
Tags
stocks
Intuit Inc
Earnings
From
CNBC.com News
Stocks making the biggest moves premarket: Moderna, Kohl's, Intuit, Analog Devices & more
May 24, 2023
Tags
Markets
Palo Alto Networks Inc
Analog Devices Inc
From
CNBC.com News
CNBC Daily Open: A debt ceiling deal won't fix everything
May 24, 2023
Tags
Moderna Inc
BlackRock Inc
PacWest Bancorp
From
CNBC.com News
CNBC Daily Open: A debt ceiling deal won’t solve everything
May 23, 2023
Tags
Broadcom Inc
Daily Open
Market Outlook
From
CNBC.com News
Here’s what Pfizer and Moderna say is next for their Covid vaccines
May 22, 2023
Tags
Pfizer Inc
Pharmaceuticals
Health & Science
From
CNBC.com News
TipRanks reveals the top 10 health care sector analysts of the past decade
May 21, 2023
Tags
Breaking News: Investing
Pfizer Inc
Weekend Brief
From
CNBC.com News
Universal flu vaccine based on mRNA tech to be tested by National Institutes of Health
May 15, 2023
Tags
US Top News and Analysis
Health care industry
US Economy
From
CNBC.com News
Here's why Covid vaccines will still be free for uninsured Americans as public health emergency ends
May 12, 2023
Tags
Biotech and Pharmaceuticals
Moderna Inc
Health care industry
From
CNBC.com News
Pfizer CEO says Medicare will likely face legal action over drug price negotiations
May 11, 2023
Tags
Health care industry
Prescription drugs
Biotech and Pharmaceuticals
From
CNBC.com News
Novavax shares rise after company unveils positive vaccine data, plan to cut 25% of workforce
May 09, 2023
Tags
Business News
Biotech and Pharmaceuticals
Moderna Inc
From
CNBC.com News
Moderna posts surprise quarterly profit despite waning demand for Covid vaccines
May 04, 2023
Tags
Biotechnology
Vaccinations
Companies
From
CNBC.com News
FDA approves GSK's RSV vaccine for older adults, world's first shot against virus
May 03, 2023
Tags
Respiratory syncytial virus
Business News
Drug approvals
From
CNBC.com News
5 things to know before the stock market opens Monday
May 01, 2023
Tags
Paramount Global
Berkshire Hathaway Inc
Investing
From
CNBC.com News
Merck revenue falls after dramatic drop in sales of Covid antiviral treatment
April 27, 2023
Tags
Breaking News: Business
Earnings
Companies
From
CNBC.com News
Treasury yields continue to fall on signs of economic contraction
April 21, 2023
Tags
Bank of America Corp
Moderna Inc
Breaking News: Markets
From
CNBC.com News
Stocks making the biggest moves midday: Tesla, IBM, American Express, AT&T and more
April 20, 2023
Tags
Breaking News: Markets
Moderna Inc
FactSet Research Systems Inc
From
CNBC.com News
Moderna teams up with IBM to put AI, quantum computing to work on mRNA technology used in vaccines
April 20, 2023
Tags
Health & Science
Science
Pharmaceuticals
From
CNBC.com News
Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales
April 19, 2023
Tags
Pfizer Inc
Pharmaceuticals
Health & Science
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.